VST.NYSEVistra CORP

Form 4: Vistra CEO Executes Pre-Planned Stock Sales

Sentiment:

Insider Transaction Report


Vistra Corp.'s President and CEO, James A. Burke, completed pre-arranged stock option exercises and subsequent share sales under a Rule 10b5-1 plan.

Summary

  • James A. Burke, President and CEO of Vistra Corp., engaged in transactions involving the company's common stock and employee stock options.
  • The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2025.
  • On October 21, 2025, Burke exercised options to acquire 4,400 shares of common stock at an exercise price of $19.68 per share.
  • On the same day, 2,005 shares were sold at $193.15 per share, which included 450 shares for cashless exercise and 1,555 shares to cover tax obligations.
  • On October 22, 2025, Burke exercised options to acquire 22,000 shares of common stock at an exercise price of $19.68 per share.
  • On October 22, 2025, 19,612 shares were sold at a weighted-average price of $188.30 per share (ranging from $188.25 to $188.74), including 2,307 shares for cashless exercise and 7,753 shares to cover taxes.
  • Following these transactions, Burke directly beneficially owns 292,642 shares of common stock.
  • Indirect beneficial ownership includes 701,514 shares through JAMEB, LP, 34,000 shares through the James A. Burke 2012 Irrevocable Trust, and 259 shares through the Marti E. Burke 2012 Irrevocable Trust.
  • Remaining directly owned 2018 Employee Stock Options (right to buy) total 75,652, with an exercise price of $19.68 and an expiration date of April 9, 2027.

Sentiment

Score: 6

Explanation: The transactions represent routine insider activity under a pre-established 10b5-1 trading plan, primarily for option exercise and tax obligations. The high sale price relative to the exercise price indicates significant gains for the executive, which is generally positive for executive retention and motivation, but the net reduction in direct ownership could be viewed neutrally by the market.

Positives

  • The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and transparent approach to managing personal holdings rather than opportunistic selling.
  • The exercise of options at a significantly lower price ($19.68) compared to the sale price (around $188-$193) indicates substantial unrealized gains on the options, reflecting positively on the company's stock performance.

Negatives

  • The sale of a significant number of shares by a key executive, even if pre-planned, could be perceived by some investors as a reduction in direct ownership, although the reasons for sale (taxes, cashless exercise) are common.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

  • The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025.

Industry Context

This Form 4 filing details routine insider transactions and does not provide information that directly relates to broader industry trends or competitive landscape analysis. Such filings are standard disclosures for executive stock activity.

Stakeholder Impact

  • Shareholders: The sale of shares by the CEO could be interpreted as a slight reduction in direct insider alignment, though the pre-planned nature and reasons (taxes, cashless exercise) mitigate this concern. The high sale price reflects strong company performance, which benefits all shareholders.

Key Dates

DateDescription
12/03/2012Date of the James A. Burke 2012 Irrevocable Trust.
10/16/2012Date of the Marti E. Burke 2012 Irrevocable Trust.
06/12/2025Date the Rule 10b5-1 trading plan was adopted by the reporting person.
10/21/2025Date of stock option exercise and subsequent share sale.
10/22/2025Date of stock option exercise and subsequent share sale.
10/23/2025Signature date of the reporting person's attorney-in-fact.
04/09/2027Expiration date of the 2018 Employee Stock Options.

Recommendation

hold

The filing details routine insider transactions by the CEO under a pre-established 10b5-1 plan, primarily for exercising options and covering tax liabilities. This is not indicative of a change in the company's fundamental outlook or a lack of confidence from management. Therefore, it does not warrant a change in investment recommendation based solely on this filing. Investors should 'hold' and continue to monitor the company's operational and financial performance.

Keywords

Vistra Corp., VST, Insider Trading, Form 4, Stock Options, Executive Compensation, James A. Burke, Rule 10b5-1, Share Sale, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.